In October 2024, the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) announced settlements with Raytheon Company, ...

Jonathan Block; Analyst; Stiefel Laboratories Inc Navann Ty Dietschi; Analyst; BNP Paribas Exane ...

Despite a hostile exchange between Treasurer Curtis Loftis and a panel of House budget writers over a $1.8 billion accounting ...

Franklin Resources, Inc. (NYSE:BEN), a global investment management organization with a market capitalization of $10.9 ...

Enveric Biosciences, Inc. ("Enveric" or the "Company"), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, ...

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ET Brian McKeon - Chief Financial Officer Andrew Emerson - Senior Vice President, Corporate & ...

Throughout 2025, Emerita will continue with its metallurgical assessment. Samples for El Cura were submitted to the lab in ...

Summary: The Finance Bill 2025 presents significant updates in both direct and indirect taxes aimed at improving business ease, reducing litigation, and widening the tax base. Direct tax proposals ...

Emerita Resources Corp. (TSX - V: EMO; OTCQB: EMOTF; FSE: LLJA) (the "Company" or "Emerita") enters 2025 following a year of ...

The US Securities and Exchange Commission (SEC) brought a number of notable enforcement proceedings against public companies in fiscal year ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...